Treatment of Heel Enthesitis in Spondyloarthritis

Initial Conservative Management

The American College of Rheumatology recommends NSAIDs as the cornerstone of initial therapy for enthesitis, with continuous dosing recommended initially until symptoms improve, then transitioning to on-demand use 1, 3, 4
Selective COX-2 inhibitors should be used in patients at high risk for gastrointestinal complications, as recommended by the European League Against Rheumatism 3, 4
Physical therapy is strongly recommended, with active supervised exercise preferred over passive modalities like massage or ultrasound, according to the American College of Sports Medicine 1
Patient-directed measures include calf-muscle stretching, cryotherapy, heel cushions, activity modification, weight loss if indicated, and avoiding flat shoes or barefoot walking, as suggested by the American Academy of Family Physicians 5

The American College of Rheumatology conditionally recommends local corticosteroid injection if enthesitis persists after 6 weeks of NSAIDs and conservative measures 1, 2, 4
Ultrasound guidance is strongly encouraged to confirm inflammation, exclude tendon rupture, and ensure accurate needle placement, as recommended by the European League Against Rheumatism 2, 4
Avoid peri-tendon injections of the Achilles, patellar, and quadriceps tendons due to significant rupture risk, as warned by the American Academy of Orthopaedic Surgeons 1, 2, 4

The American College of Rheumatology recommends TNF inhibitors as effective for enthesitis and represents the traditional first biologic choice 1, 6
IL-17 inhibitors (secukinumab, ixekizumab) are strongly recommended for active disease despite NSAIDs, particularly when skin psoriasis is prominent, as recommended by the National Psoriasis Foundation 1, 6
Conventional synthetic DMARDs (methotrexate, sulfasalazine, leflunomide) are NOT effective for isolated enthesitis and should not be used for this indication, as stated by the European League Against Rheumatism 1, 3, 4

The treatment algorithm recommends weeks 0-6: NSAIDs (continuous dosing) + physical therapy + patient-directed measures, as suggested by the American College of Rheumatology 1, 2
If no improvement at 6 weeks, add local corticosteroid injection (ultrasound-guided, perientheseal), as recommended by the American College of Rheumatology 1, 2
If no improvement at 3 months, initiate biologic DMARD (TNF inhibitor or IL-17 inhibitor), as recommended by the European League Against Rheumatism 1

Systemic corticosteroids are strongly recommended against for enthesitis management, as warned by the American College of Rheumatology 1, 4
Night splinting and customized orthotic devices may be added as adjunctive measures, as suggested by the American Academy of Family Physicians 2, 5